• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Routine monitoring of serum vancomycin concentrations: can waiting be justified?

作者信息

Rodvold K A, Zokufa H, Rotschafer J C

机构信息

Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago.

出版信息

Clin Pharm. 1987 Aug;6(8):655-8.

PMID:3691014
Abstract
摘要

相似文献

1
Routine monitoring of serum vancomycin concentrations: can waiting be justified?血清万古霉素浓度的常规监测：等待是否合理？
Clin Pharm. 1987 Aug;6(8):655-8.
2
Routine monitoring of serum vancomycin concentrations: waiting for proof of its value.血清万古霉素浓度的常规监测：等待其价值的证据。
Clin Pharm. 1987 Aug;6(8):652-4.
3
Vancomycin population pharmacokinetics in neonates.新生儿万古霉素群体药代动力学
Clin Pharmacol Ther. 2000 Apr;67(4):360-7. doi: 10.1067/mcp.2000.105353.
4
Vancomycin pharmacokinetics and dosage requirements in hematologic malignancies.血液系统恶性肿瘤中万古霉素的药代动力学及剂量需求
Clin Pharm. 1993 Jul;12(7):515-20.
5
Individualizing vancomycin dosing regimens: an evaluation of two pharmacokinetic dosing programs in critically ill patients.
Pharmacotherapy. 1994 Mar-Apr;14(2):196-201.
6
[Pharmacologic clinical monitoring of serum vancomycin levels in pediatric patients].[儿科患者血清万古霉素水平的药理临床监测]
Rev Invest Clin. 2003 May-Jun;55(3):276-80.
7
Reduced vancomycin clearance despite unchanged creatinine clearance in patients treated with vancomycin for longer than 4 weeks.
Ther Drug Monit. 2008 Feb;30(1):103-7. doi: 10.1097/FTD.0b013e318164f781.
8
Prospective evaluation of a vancomycin dosage guideline for neonates.新生儿万古霉素剂量指南的前瞻性评估。
Clin Pharm. 1991 Feb;10(2):129-32.
9
Vancomycin prophylaxis in cardiac operations: determination of an optimal dosage regimen.
J Thorac Cardiovasc Surg. 1983 Jun;85(6):933-5.
10
Evaluation of vancomycin dosing protocols to achieve therapeutic serum concentrations in patients receiving high-flux haemodialysis.评估万古霉素给药方案以在接受高通量血液透析的患者中达到治疗性血清浓度。
Int J Antimicrob Agents. 2014 Apr;43(4):384-5. doi: 10.1016/j.ijantimicag.2014.01.002. Epub 2014 Jan 27.

引用本文的文献

1
Vancomycin Serum Concentration Monitoring : The Middle Ground is Best.万古霉素血清浓度监测：中庸之道最佳。
Clin Drug Investig. 1996 Aug;12(2):105-18. doi: 10.2165/00044011-199612020-00006.
2
The serum vancomycin assay: A test of historic interest.血清万古霉素检测：一项具有历史意义的检测。
Can J Infect Dis. 1995 Mar;6(2):67-8. doi: 10.1155/1995/154760.
3
Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.肥胖患者抗菌药物的剂量调整：应用临床药代动力学
Clin Pharmacokinet. 2000 May;38(5):415-26. doi: 10.2165/00003088-200038050-00003.
4
Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique.采用贝叶斯预测技术测定肥胖对万古霉素药代动力学参数的影响。
Antimicrob Agents Chemother. 1993 Mar;37(3):436-40. doi: 10.1128/AAC.37.3.436.
5
Vancomycin pharmacokinetics in patients with various degrees of renal function.不同肾功能程度患者的万古霉素药代动力学
Antimicrob Agents Chemother. 1988 Jun;32(6):848-52. doi: 10.1128/AAC.32.6.848.
6
Vancomycin ototoxicity and nephrotoxicity. A review.万古霉素的耳毒性和肾毒性。综述。
Med Toxicol Adverse Drug Exp. 1988 Sep-Oct;3(5):376-86. doi: 10.1007/BF03259891.
7
Clinical pharmacokinetics of antibacterial drugs in neonates.抗菌药物在新生儿中的临床药代动力学。
Clin Pharmacokinet. 1990 Oct;19(4):280-318. doi: 10.2165/00003088-199019040-00003.
8
An updated comparison of drug dosing methods. Part IV: Vancomycin.药物给药方法的最新比较。第四部分：万古霉素。
Clin Pharmacokinet. 1991 Jun;20(6):463-76. doi: 10.2165/00003088-199120060-00003.
9
Teicoplanin in perspective. A critical comparison with vancomycin.
Pharm Weekbl Sci. 1991 Aug 23;13(4):153-60. doi: 10.1007/BF01957739.
10
Treatment options for the pharmacological therapy of neonatal meningitis.新生儿脑膜炎药物治疗的治疗选择。
Drugs. 1992 May;43(5):700-12. doi: 10.2165/00003495-199243050-00006.